FIELD: experimental medicine, radiation biology.
SUBSTANCE: invention can be used to treat radiation sickness caused by external exposure. The invention relates to medicine, namely to therapy and radiation biology, and is intended for the treatment of acute radiation sickness. An immunomodulating agent containing formic aldehyde in an amount of 0.073–0.075% in an isotonic sodium chloride solution of 0.85–0.95% concentration is used as an agent for intramuscular injections for the treatment of acute radiation sickness.
EFFECT: use of the invention provides a radioprotective effect of the agent due to its ability to activate the cell repair system.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINE FOR THE TREATMENT OF CARDIOVASCULAR AND CEREBROVASCULAR DISEASES | 2020 |
|
RU2790663C1 |
| MITOCHONDRIAL DYSFUNCTION CORRECTION AGENT | 2021 |
|
RU2765467C1 |
| COMPOSITION FOR MAINTAINING THE NORMAL STATE OF HOMEOSTASIS AND MEDICINAL PRODUCT BASED THEREON | 2021 |
|
RU2784067C1 |
| AGENT FOR TREATING CORONAVIRUS, RETROVIRUS INFECTIONS AND HEPATITIS C | 2020 |
|
RU2738719C1 |
| REPRODUCTIVE FUNCTION ENHANCER | 2019 |
|
RU2728709C1 |
| AGENT POSSESSING CHOLESTEROL-REGULATING ACTION | 2007 |
|
RU2352331C1 |
| MEANS FOR STEM CELLS ACTIVATION | 2008 |
|
RU2376985C1 |
| MEANS FOR CATTLE LEUKEMIA PREVENTION AND METHOD FOR ITS APPLICATION | 2016 |
|
RU2631607C1 |
| N-(6-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-5H-PYRIMIDINESULFONE)-N′- ISONICOTINOYL HYDRAZIDE DISODIUM SALT ELICITING ANTIBACTERIAL AND IMMUNOTROPIC ACTIVITY AND MEDICINAL AGENT BASED ON THEREOF | 1999 |
|
RU2191015C2 |
| MEDICATION, WHICH POSSESES IMMUNOSTIMULATING ACTIVITY | 2009 |
|
RU2403054C1 |
